Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Debt to Equity (2018 - 2025)

TELA Bio has reported Debt to Equity over the past 7 years, most recently at $8.82 for Q4 2025.

  • Quarterly results put Debt to Equity at $8.82 for Q4 2025, up 510.04% from a year ago — trailing twelve months through Dec 2025 was $8.82 (up 510.04% YoY), and the annual figure for FY2025 was $8.82, up 510.04%.
  • Debt to Equity for Q4 2025 was $8.82 at TELA Bio, down from $26.65 in the prior quarter.
  • Over the last five years, Debt to Equity for TELA hit a ceiling of $26.65 in Q3 2025 and a floor of -$25.69 in Q2 2022.
  • Median Debt to Equity over the past 5 years was $2.21 (2025), compared with a mean of $3.24.
  • Peak annual rise in Debt to Equity hit 1314.87% in 2024, while the deepest fall reached 594.44% in 2024.
  • TELA Bio's Debt to Equity stood at $1.57 in 2021, then soared by 78.08% to $2.79 in 2022, then decreased by 23.1% to $2.15 in 2023, then crashed by 32.66% to $1.45 in 2024, then soared by 510.04% to $8.82 in 2025.
  • The last three reported values for Debt to Equity were $8.82 (Q4 2025), $26.65 (Q3 2025), and $4.51 (Q2 2025) per Business Quant data.